{"id":51525,"date":"2019-12-19T02:00:00","date_gmt":"2019-12-19T06:00:00","guid":{"rendered":"https:\/\/www.nationaldrugscreening.com\/?p=51525"},"modified":"2022-11-29T16:23:31","modified_gmt":"2022-11-29T21:23:31","slug":"clearinghouse-effective-date-fast-approaching","status":"publish","type":"post","link":"https:\/\/www.nationaldrugscreening.com\/blogs\/clearinghouse-effective-date-fast-approaching\/","title":{"rendered":"Clearinghouse Effective Date Fast Approaching"},"content":{"rendered":"\n<p>As an employer, are you regulated by the<a href=\"https:\/\/clearinghouse.fmcsa.dot.gov\/\"> Federal Motor Carrier Safety Administration (FMCSA)<\/a>? If yes, we hope you are aware of the new FMCSA Clearinghouse.&nbsp; As of January 6, 2020, you must be registered in the Clearinghouse and you must Query any new drivers you are hiring.&nbsp; These drivers must also be registered into the Clearinghouse and must provide consent to this query.&nbsp; You must receive back the cleared query prior to allowing the driver to perform safety sensitive duties.<\/p>\n\n\n\n<p><strong>Clearinghouse Consultation and Assistance is Available<\/strong><\/p>\n\n\n\n<p>Your MRO will report positive drug test results.&nbsp; There are <a href=\"https:\/\/clearinghouseservices.com\/blog\/page\/3\/\">5 major employer responsibilities<\/a> in the Clearinghouse. <a href=\"https:\/\/clearinghouseservices.com\/employer-memberships\/\">&nbsp;ClearinghouseServices.com <\/a>can help you with those employer responsibilities while providing ongoing consultation and guidance with the Clearinghouse.<\/p>\n\n\n\n<p>ClearinghouseServices.com offers services to employers and to service agents in the DOT drug and alcohol testing program.&nbsp; Employers five main obligations regarding the Clearinghouse are:<\/p>\n\n\n\n<ul>\n<li>Queries of new drivers<\/li>\n\n\n\n<li>Annual queries of all existing drivers<\/li>\n\n\n\n<li>Reporting alcohol test positives, employer determined refusals to test and actual knowledge, as defined in Part \u00a7 382.107<\/li>\n\n\n\n<li>Reporting negative return to duty tests and completion of follow up testing programs<\/li>\n\n\n\n<li>Updating policies and education programs to notify drivers of what information will be reported to the Clearinghouse<\/li>\n<\/ul>\n\n\n\n<p>Employers who do not comply with the Clearinghouse requirements are subject to civil and\/or criminal penalties not to exceed $2,500 for each offense.<\/p>\n\n\n\n<p><strong>Discounts Available<\/strong><\/p>\n\n\n\n<p>Now through 12\/31\/2019. This is a great opportunity to stay compliant, get the job done and save money.&nbsp; Use <strong>Coupon Code&nbsp; &#8211; 2019DISCOUNT &#8211; <\/strong>to receive the 50% off all services from ClearinghouseServices.com. Additional discounts are available to clients of National Drug Screening &#8211; call 877-345-2425 and ask for the NDS discount.<\/p>\n\n\n\n<p>ClearinghouseServices.com offers three levels of membership to employers for queries, reporting, assistance, guidance and consultation.<\/p>\n\n\n\n<ul>\n<li><a href=\"https:\/\/clearinghouseservices.com\/register\/owner-operator-membership\/\">Owner Operator Membership<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/clearinghouseservices.com\/register\/silver-membership\/\">Silver Membership for employers with up to 20 drivers <\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/clearinghouseservices.com\/register\/gold-membership\/\">Gold Membership for employers with 21 + drivers<\/a><\/li>\n<\/ul>\n\n\n\n<p>Now is the time to get ready for the FMCSA Clearinghouse, reach out for assistance at 877-345-2425 or <a href=\"mailto:info@clearinghouseservices.com\">info@clearinghouseservices.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>As an employer, are you regulated by the Federal Motor Carrier Safety Administration (FMCSA)? If yes, we hope you are aware of the new FMCSA Clearinghouse.&nbsp; As of January 6, 2020, you must be registered in the Clearinghouse and you must Query any new drivers you are hiring.&nbsp; These drivers must also be registered into [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":54068,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_seopress_robots_primary_cat":"none","_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"51210,51177,51586,51530,51527,51524","_relevanssi_noindex_reason":"","footnotes":""},"categories":[130],"tags":[],"acf":[],"_links":{"self":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/posts\/51525"}],"collection":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/comments?post=51525"}],"version-history":[{"count":0,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/posts\/51525\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/media\/54068"}],"wp:attachment":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/media?parent=51525"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/categories?post=51525"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/tags?post=51525"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}